Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older

NCT01992094 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2680

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: QIVc
BIOLOGICAL: TIV1c
BIOLOGICAL: TIV2c

Sponsor

Novartis Vaccines